why choose us

First received: December 20, 2023

Clinical Trial: A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Male

Study Type: INTERVENTIONAL


Official Title: An Open-label, Two-part Study of the Disposition and Absolute Bioavailability of [14C]-LY3549492 in Healthy Participants

Brief Summary: The main purpose of this study is to measure how much of the study drug gets into the bloodstream and how long it takes the body to get rid of it.This study will be conducted in healthy males and has two parts.In Part A, participants will receive carbon-14 (14C) radiolabeled LY3549492 ([14C] LY3549492) given by mouth.In Part B, participants will receive LY3549492 by mouth.Three hours later, participants will receive [14C] LY3549492 given into a vein.The radioactive substance C14 will be incorporated into the study…

Read more